1106 related articles for article (PubMed ID: 29027218)
1. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
Garg AD; Agostinis P
Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunogenicity, danger signals, and DAMPs: what, when, and how?
Garg AD; Dudek AM; Agostinis P
Biofactors; 2013; 39(4):355-67. PubMed ID: 23900966
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.
Garg AD; Galluzzi L; Apetoh L; Baert T; Birge RB; Bravo-San Pedro JM; Breckpot K; Brough D; Chaurio R; Cirone M; Coosemans A; Coulie PG; De Ruysscher D; Dini L; de Witte P; Dudek-Peric AM; Faggioni A; Fucikova J; Gaipl US; Golab J; Gougeon ML; Hamblin MR; Hemminki A; Herrmann M; Hodge JW; Kepp O; Kroemer G; Krysko DV; Land WG; Madeo F; Manfredi AA; Mattarollo SR; Maueroder C; Merendino N; Multhoff G; Pabst T; Ricci JE; Riganti C; Romano E; Rufo N; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Vacchelli E; Vandenabeele P; Vandenberk L; Van den Eynde BJ; Van Gool S; Velotti F; Zitvogel L; Agostinis P
Front Immunol; 2015; 6():588. PubMed ID: 26635802
[TBL] [Abstract][Full Text] [Related]
4. Decoding immunogenic cell death from a dendritic cell perspective.
Janssens S; Rennen S; Agostinis P
Immunol Rev; 2024 Jan; 321(1):350-370. PubMed ID: 38093416
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F
Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.
Guo ZS; Liu Z; Bartlett DL
Front Oncol; 2014; 4():74. PubMed ID: 24782985
[TBL] [Abstract][Full Text] [Related]
8. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.
Radogna F; Diederich M
Biochem Pharmacol; 2018 Jul; 153():12-23. PubMed ID: 29438676
[TBL] [Abstract][Full Text] [Related]
9. The renaissance of anti-neoplastic immunity from tumor cell demise.
Ma Y; Pitt JM; Li Q; Yang H
Immunol Rev; 2017 Nov; 280(1):194-206. PubMed ID: 29027231
[TBL] [Abstract][Full Text] [Related]
10. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
Inoue H; Tani K
Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
[TBL] [Abstract][Full Text] [Related]
11. Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system.
Martin SJ
FEBS J; 2016 Jul; 283(14):2599-615. PubMed ID: 27273805
[TBL] [Abstract][Full Text] [Related]
12. The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond.
van Vliet AR; Martin S; Garg AD; Agostinis P
Semin Cancer Biol; 2015 Aug; 33():74-85. PubMed ID: 25882379
[TBL] [Abstract][Full Text] [Related]
13. Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer.
Ma J; Ramachandran M; Jin C; Quijano-Rubio C; Martikainen M; Yu D; Essand M
Cell Death Dis; 2020 Jan; 11(1):48. PubMed ID: 31969562
[TBL] [Abstract][Full Text] [Related]
14. Targeting immunogenic cell death in cancer.
Ahmed A; Tait SWG
Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
[TBL] [Abstract][Full Text] [Related]
15. Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies.
van Vloten JP; Workenhe ST; Wootton SK; Mossman KL; Bridle BW
J Immunol; 2018 Jan; 200(2):450-458. PubMed ID: 29311387
[TBL] [Abstract][Full Text] [Related]
16. Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.
Garg AD; Vandenberk L; Fang S; Fasche T; Van Eygen S; Maes J; Van Woensel M; Koks C; Vanthillo N; Graf N; de Witte P; Van Gool S; Salven P; Agostinis P
Cell Death Differ; 2017 May; 24(5):832-843. PubMed ID: 28234357
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
18. Danger signalling during cancer cell death: origins, plasticity and regulation.
Garg AD; Martin S; Golab J; Agostinis P
Cell Death Differ; 2014 Jan; 21(1):26-38. PubMed ID: 23686135
[TBL] [Abstract][Full Text] [Related]
19. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of immunogenic cancer cell death.
Tesniere A; Panaretakis T; Kepp O; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
Cell Death Differ; 2008 Jan; 15(1):3-12. PubMed ID: 18007663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
